BDBM50281553 (S)-2-[(S)-2-((S)-2-{N-[2-(2-{N-[(S)-3-(4-Aminooxy-phenyl)-2-hydrazino-propionyl]-hydrazino}-acetylamino)-acetyl]-hydrazino}-3-phenyl-propionylamino)-4-methylsulfanyl-butyrylamino]-3-methyl-butyramide::CHEMBL132743

SMILES CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)N(N)C(=O)CNC(=O)CN(N)C(=O)[C@H](Cc1ccc(ON)cc1)NN)C(=O)N[C@@H](C(C)C)C(N)=O

InChI Key InChIKey=USSSFJLCBNNKOE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50281553   

TargetMu-type opioid receptor(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50281553((S)-2-[(S)-2-((S)-2-{N-[2-(2-{N-[(S)-3-(4-Aminooxy...)
Affinity DataIC50: 107nMAssay Description:Concentration required for 50% inhibition of [3H]DAGO binding to mu opioid receptor in crude rat brain homogenatesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2010
Entry Details Article